STOCK TITAN

Encompass Health (EHC) director receives 39 RSUs from dividend-linked award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

SCHLICHTING NANCY M reported acquisition or exercise transactions in this Form 4 filing.

Encompass Health Corp director Nancy M. Schlichting received an automatic grant of 39 restricted stock units (RSUs) tied to a dividend payment. These RSUs were credited on April 15, 2026 in connection with Encompass Health’s common stock dividend of $0.19 per share.

The RSU credit was calculated based on the number of RSUs already in the director’s account, the per share dividend, and the closing stock price of $105.24 on the dividend payment date. After this award, Schlichting directly holds 21,298 shares of Encompass Health common stock. This is a routine, non-cash compensation-related accrual rather than an open-market stock purchase or sale.

Positive

  • None.

Negative

  • None.
Insider SCHLICHTING NANCY M
Role Director
Type Security Shares Price Value
Grant/Award Encompass Health Common Stock 39 $0.00 --
Holdings After Transaction: Encompass Health Common Stock — 21,298 shares (Direct)
Footnotes (1)
  1. [object Object]
RSUs awarded 39 RSUs Dividend-linked RSU grant on April 15, 2026
Dividend per share $0.19 per share Common stock dividend paid April 15, 2026
Closing stock price $105.24 Encompass Health closing price on dividend payment date
Shares owned after transaction 21,298 shares Director’s direct Encompass Health holdings following RSU award
restricted stock units financial
"additional restricted stock units ("RSUs") are credited to each non-employee director's account"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend payments financial
"RSUs are credited to each non-employee director's account in connection with common stock dividend payments"
dividend record date financial
"the number of the RSUs in each director's account on the associated dividend record date"
dividend payment date financial
"the closing price on the dividend payment date"
non-employee director financial
"additional restricted stock units ("RSUs") are credited to each non-employee director's account"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SCHLICHTING NANCY M

(Last)(First)(Middle)
9001 LIBERTY PARKWAY

(Street)
BIRMINGHAM ALABAMA 35242

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Encompass Health Common Stock04/15/2026A39(1)A$021,298D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $105.24. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.
/s/ Patrick Darby, attorney-in-fact for Nancy M. Schlichting04/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Encompass Health (EHC) director Nancy Schlichting report on this Form 4?

Nancy Schlichting reported receiving 39 restricted stock units (RSUs) of Encompass Health common stock. The RSUs were automatically credited as a dividend equivalent award, increasing her direct holdings to 21,298 shares after the transaction.

Is the Encompass Health (EHC) Form 4 a stock purchase or sale?

The Form 4 does not show a stock purchase or sale. It reports a grant of 39 restricted stock units credited as compensation linked to a dividend, with no cash-paid open-market transaction involved.

How were the 39 RSUs for Encompass Health (EHC) calculated for the director?

The 39 RSUs were calculated using the RSUs already in the director’s account on the dividend record date, the $0.19 per share dividend, and the $105.24 closing stock price on April 15, 2026, the dividend payment date.

What is Nancy Schlichting’s Encompass Health (EHC) share ownership after this Form 4?

After the RSU grant, Nancy Schlichting directly owns 21,298 shares of Encompass Health common stock. This figure reflects her position following the automatic crediting of 39 additional restricted stock units related to the dividend.

Why did Encompass Health (EHC) credit RSUs to its non-employee director?

RSUs were credited under outstanding restricted stock unit award agreements for non-employee directors. These agreements provide that additional RSUs are added when Encompass Health pays common stock dividends, aligning director compensation with shareholder dividend activity.